| Name | Title | Contact Details |
|---|
OneOncology is a partnership of independent community oncology practices committed to driving the future of cancer care delivery through a patient-centric, physician-driven, and technology-powered model to help improve the lives of everyone living with cancer. OneOncology empowers community oncology practices by supporting the entire continuum of care, including prevention and diagnosis, research and treatment, and long-term survivorship, palliative, and hospice care. Our technology is powered by the Flatiron suite of services to provide access to key clinical and operational data and the latest research via a cloud-based network. This comprehensive approach supports community oncologists` transition to value-based care and commitment to providing their patients with access to best-in-class healthcare, close to home. For OneOncology, cancer is personal, and the mission is critical. Working together with world class oncologists, OneOncology looks to drive the change that community cancer needs through continual learning, creative and smart evolution, and a collective desire to positively impact the lives of every person touched by cancer.
Ellie Diagnostics was founded to offer vets a simpler way to diagnose and treat animals with confidence, while helping animals live longer, healthier lives.
Lumilife is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.
Strategic Medical Communications is a Woodbridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.